CD14 and melanoma: In addition—following the in vitro reconstitution of a human melanoma TME using tumor lines (BLM, Mel624 or A375)—PGE2 and IL-6 produced by the tumor transform cDC2s into CD14+ DCs, characterized by an immunosuppressive phenotype [91].